REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/10/2025
Back to search
Official data from USPTO
PHARMAVISION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMAVISION
ST13
US500000078696440Class
42, 44
Filing
78696440
Registration
3153515
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
10/11/2025
Trademark type
Word
Nice classes
42, 44
Filing date
08/19/2005
Registration date
10/10/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/09/2016
Last transaction
10/11/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
05/20/2005
First use in commerce
05/20/2005
Drawing code
4
Owner type
03
Owner location
Evanston, IL
Examiner
JACKSON,STEVEN W
Law office
L70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
MedSphere Corp.
Representatives
TOGAI ATAC ATOM LAW GROUP LLC
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing information in the field of the pharmaceutical research and biotechnology industries via the Internet
Class 44
Providing information in the field of the health care industry via the Internet
Publications
History of USPTO decisions and trademark events.
41 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/31/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/31/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/31/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/31/2018
CORV
REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
10/31/2018
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/31/2018
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/09/2016
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/09/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/09/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/09/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
11/23/2015
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/10/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/05/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/05/2013
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03/29/2013
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
01/08/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/08/2013
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
12/07/2012
E815
TEAS SECTION 8 & 15 RECEIVED
12/07/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/08/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/08/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
10/10/2006
PUBO
PUBLISHED FOR OPPOSITION
07/18/2006
NPUB
NOTICE OF PUBLICATION
06/28/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/27/2006
ALIE
ASSIGNED TO LIE
05/26/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/22/2006
XAEC
EXAMINER'S AMENDMENT ENTERED
05/17/2006
GNEA
EXAMINERS AMENDMENT E-MAILED
05/16/2006
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/16/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/10/2006
GNRT
NON-FINAL ACTION E-MAILED
05/10/2006
CNRT
NON-FINAL ACTION WRITTEN
05/10/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/04/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/24/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/24/2006
GNRT
NON-FINAL ACTION E-MAILED
03/08/2006
CNRT
NON-FINAL ACTION WRITTEN
03/08/2006
DOCK
ASSIGNED TO EXAMINER
03/08/2006
NWAP
NEW APPLICATION ENTERED
08/29/2005
Continuous trademark protection
Get notified about every new filing that threatens PHARMAVISION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.